CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease.
- DOI
- 10.1016/j.omtn.2018.03.007
- Published
- 2018 Jun 1
- Container
- Molecular therapy. Nucleic acids
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtn.2018.03.007,
title = {CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease.},
author = {György B and Lööv C and Zaborowski MP and Takeda S and Kleinstiver BP and Commins C and Kastanenka K and Mu D and Volak A and Giedraitis V and Lannfelt L and Maguire CA and Joung JK and Hyman BT and Breakefield XO and Ingelsson M},
year = {2018},
journal = {Molecular therapy. Nucleic acids},
doi = {10.1016/j.omtn.2018.03.007},
url = {https://doi.org/10.1016/j.omtn.2018.03.007}
}RIS
TY - JOUR TI - CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease. AU - György B AU - Lööv C AU - Zaborowski MP AU - Takeda S AU - Kleinstiver BP AU - Commins C AU - Kastanenka K AU - Mu D AU - Volak A AU - Giedraitis V AU - Lannfelt L AU - Maguire CA AU - Joung JK AU - Hyman BT AU - Breakefield XO AU - Ingelsson M PY - 2018 JO - Molecular therapy. Nucleic acids DO - 10.1016/j.omtn.2018.03.007 UR - https://doi.org/10.1016/j.omtn.2018.03.007 ER -
APA
B, G., C, L., MP, Z., S, T., BP, K., C, C., K, K., D, M., A, V., V, G., L, L., CA, M., JK, J., BT, H., XO, B., & M, I. (2018). CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2018.03.007
Source records
- pubmed · retrieved 2026-09-25T15:35:59.437Z